'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
about
Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy.Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes.Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesThe Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 DiabetesRecent advances in glucose-lowering treatment to reduce diabetic kidney disease.Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.Body fluid peptide and protein signatures in diabetic kidney diseases.Effects of glycaemic management on diabetic kidney disease.SUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes.Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice.Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate.Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review.The Landscape of Diabetic Kidney Disease in the United States.Benefits of a 12-week lifestyle modification program including diet and combined aerobic and resistance exercise on albuminuria in diabetic and non-diabetic Japanese populations.Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.
P2860
Q35248154-F86D94C0-813B-4915-BBB3-C9C037BE95F5Q35902228-1BBDFB1D-844A-4593-80F1-4693F7900638Q35903097-1CB7C11A-586B-4267-A358-4115597CE803Q35951795-F02E7A66-0A22-40EE-85DA-94C5FABA8B21Q38442040-DC90BB0C-52D9-4BD3-A66D-4D0159C90894Q38546268-9AF90EBE-BB51-40D1-A36A-134FF84880C0Q38553924-49F68245-9178-494C-822C-F9FD17DE6683Q39345204-0F163CAC-3D77-43C3-AC32-A31208E38985Q40082377-79C20688-7560-4DE0-BED8-EF2930E8BA99Q41663017-3EBCACDC-6FC8-427B-9AEE-D1DB957FA1B8Q42228384-E9320696-4BD7-455C-B725-87CB33CCEA84Q47095989-30AE6A91-9874-43F4-8052-1A86E6F13D67Q49199995-58399611-E1C0-49AB-9A1C-86A87269B94EQ49862755-DCF20423-DFA4-4F7F-A3F9-48ACBAFC2D2AQ51306844-0BD97A71-D4DE-4A65-866E-E438A2C452FAQ55312504-731C1BD6-91DB-4265-A250-0C7982BF50BA
P2860
'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
@en
type
label
'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
@en
prefLabel
'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
@en
P356
P1433
P1476
'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
@en
P2093
Richard J MacIsaac
P2888
P356
10.1038/KI.2014.98
P407
P577
2014-04-09T00:00:00Z
P5875
P6179
1002746892